KYMR logo

Kymera Therapeutics, Inc. (KYMR) Working Capital

Annual Working Capital:

$442.50M+$122.88M(+38.44%)
December 31, 2024

Summary

  • As of today, KYMR annual working capital is $442.50 million, with the most recent change of +$122.88 million (+38.44%) on December 31, 2024.
  • During the last 3 years, KYMR annual working capital has risen by +$83.77 million (+23.35%).
  • KYMR annual working capital is now at all-time high.

Performance

KYMR Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKYMRbalance sheet metrics

Quarterly Working Capital:

$456.72M-$184.06M(-28.72%)
September 30, 2025

Summary

  • As of today, KYMR quarterly working capital is $456.72 million, with the most recent change of -$184.06 million (-28.72%) on September 30, 2025.
  • Over the past year, KYMR quarterly working capital has dropped by -$45.46 million (-9.05%).
  • KYMR quarterly working capital is now -28.72% below its all-time high of $640.79 million, reached on June 30, 2025.

Performance

KYMR Quarterly Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKYMRbalance sheet metrics

Working Capital Formula

Working Capital = Current Assets − Current Liabilities

KYMR Working Capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+38.4%-9.1%
3Y3 Years+23.4%+13.4%
5Y5 Years+659.3%+140.3%

KYMR Working Capital Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Yearat high+38.4%-28.7%+46.1%
5Y5-Yearat high+659.3%-28.7%+140.3%
All-TimeAll-Timeat high+1092.6%-28.7%+683.7%

KYMR Working Capital History

DateAnnualQuarterly
Sep 2025
-
$456.72M(-28.7%)
Jun 2025
-
$640.79M(+45.0%)
Mar 2025
-
$441.96M(-0.1%)
Dec 2024
$442.50M(+38.4%)
$442.50M(-11.9%)
Sep 2024
-
$502.18M(+8.4%)
Jun 2024
-
$463.26M(-3.7%)
Mar 2024
-
$481.12M(+50.5%)
Dec 2023
$319.63M(-8.2%)
$319.63M(+2.3%)
Sep 2023
-
$312.53M(-5.5%)
Jun 2023
-
$330.80M(-5.4%)
Mar 2023
-
$349.62M(+0.4%)
Dec 2022
$348.07M
$348.07M(-13.6%)
DateAnnualQuarterly
Sep 2022
-
$402.90M(+27.8%)
Jun 2022
-
$315.27M(-8.1%)
Mar 2022
-
$343.04M(-4.4%)
Dec 2021
$358.73M(+87.1%)
$358.73M(-20.1%)
Sep 2021
-
$449.24M(+75.4%)
Jun 2021
-
$256.12M(+11.0%)
Mar 2021
-
$230.65M(+20.3%)
Dec 2020
$191.72M(+229.0%)
$191.72M(+0.9%)
Sep 2020
-
$190.08M(+64.4%)
Jun 2020
-
$115.62M(+98.4%)
Dec 2019
$58.27M(+57.1%)
$58.27M
Dec 2018
$37.10M
-

FAQ

  • What is Kymera Therapeutics, Inc. annual working capital?
  • What is the all-time high annual working capital for Kymera Therapeutics, Inc.?
  • What is Kymera Therapeutics, Inc. annual working capital year-on-year change?
  • What is Kymera Therapeutics, Inc. quarterly working capital?
  • What is the all-time high quarterly working capital for Kymera Therapeutics, Inc.?
  • What is Kymera Therapeutics, Inc. quarterly working capital year-on-year change?

What is Kymera Therapeutics, Inc. annual working capital?

The current annual working capital of KYMR is $442.50M

What is the all-time high annual working capital for Kymera Therapeutics, Inc.?

Kymera Therapeutics, Inc. all-time high annual working capital is $442.50M

What is Kymera Therapeutics, Inc. annual working capital year-on-year change?

Over the past year, KYMR annual working capital has changed by +$122.88M (+38.44%)

What is Kymera Therapeutics, Inc. quarterly working capital?

The current quarterly working capital of KYMR is $456.72M

What is the all-time high quarterly working capital for Kymera Therapeutics, Inc.?

Kymera Therapeutics, Inc. all-time high quarterly working capital is $640.79M

What is Kymera Therapeutics, Inc. quarterly working capital year-on-year change?

Over the past year, KYMR quarterly working capital has changed by -$45.46M (-9.05%)
On this page